Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
34
2024
2237
5.160
Why?
Machine Learning
7
2024
505
2.270
Why?
Stroke Volume
17
2025
617
1.980
Why?
Methadone
5
2023
101
1.550
Why?
Adrenergic beta-Antagonists
10
2025
323
1.530
Why?
Pregnancy Complications, Cardiovascular
5
2022
77
1.500
Why?
Buprenorphine
3
2023
173
1.380
Why?
Cardiomyopathies
5
2022
350
1.360
Why?
United States Food and Drug Administration
5
2024
208
1.250
Why?
Decision Support Systems, Clinical
6
2024
236
1.240
Why?
Pharmacogenetics
5
2024
180
1.160
Why?
Cardiomyopathy, Dilated
9
2025
389
1.150
Why?
Adverse Drug Reaction Reporting Systems
4
2024
77
1.130
Why?
Arrhythmias, Cardiac
6
2023
333
1.110
Why?
Electronic Health Records
7
2024
1070
1.030
Why?
Cytochrome P-450 CYP2C19
4
2024
25
1.010
Why?
Hospitalization
10
2024
2200
0.910
Why?
Propanolamines
3
2019
96
0.910
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
445
0.880
Why?
Workflow
1
2024
165
0.820
Why?
Telemedicine
4
2024
862
0.800
Why?
Torsades de Pointes
4
2016
24
0.750
Why?
Seasons
1
2024
547
0.740
Why?
Pulmonary Edema
1
2021
108
0.720
Why?
Humans
85
2025
137782
0.710
Why?
Coffee
1
2021
17
0.700
Why?
Stroke
2
2021
1120
0.680
Why?
Pharmacogenomic Testing
4
2022
64
0.670
Why?
Platelet Aggregation Inhibitors
1
2024
463
0.660
Why?
Defibrillators, Implantable
2
2021
315
0.650
Why?
Aged
31
2025
24001
0.630
Why?
Prosthesis Failure
1
2020
123
0.610
Why?
Prosthesis-Related Infections
1
2020
95
0.610
Why?
Long QT Syndrome
3
2016
70
0.600
Why?
Device Removal
1
2020
136
0.600
Why?
Spironolactone
1
2019
36
0.600
Why?
Mobile Applications
1
2021
183
0.600
Why?
Pacemaker, Artificial
1
2020
119
0.590
Why?
United States
21
2024
14870
0.590
Why?
Mineralocorticoid Receptor Antagonists
1
2019
54
0.590
Why?
Medical Records
2
2019
177
0.580
Why?
Coronary Disease
1
2021
385
0.580
Why?
Diabetes Mellitus
2
2024
1041
0.580
Why?
Biomedical Research
2
2024
700
0.570
Why?
Periodicals as Topic
1
2020
211
0.560
Why?
Mortality
3
2019
363
0.550
Why?
Retrospective Studies
21
2024
15682
0.550
Why?
Risk Assessment
8
2024
3461
0.530
Why?
Hypertension, Pregnancy-Induced
1
2018
69
0.530
Why?
Female
48
2025
73465
0.520
Why?
Receptors, Transforming Growth Factor beta
1
2017
59
0.520
Why?
Analgesics, Opioid
2
2023
1002
0.520
Why?
Hospital Records
1
2016
12
0.520
Why?
Proteoglycans
1
2017
107
0.510
Why?
Atrial Fibrillation
3
2019
390
0.510
Why?
Ventricular Function, Left
5
2025
536
0.500
Why?
Hospital Mortality
6
2024
911
0.500
Why?
Artificial Intelligence
1
2019
282
0.490
Why?
Survival
1
2015
38
0.480
Why?
Disease Management
1
2020
629
0.480
Why?
Tetrazoles
1
2015
41
0.470
Why?
Middle Aged
29
2025
33554
0.470
Why?
Male
40
2025
67906
0.470
Why?
Biphenyl Compounds
1
2015
63
0.460
Why?
Muscle Proteins
2
2025
231
0.460
Why?
Myocardial Infarction
3
2018
1047
0.450
Why?
Research Design
1
2020
1139
0.430
Why?
Ventricular Remodeling
3
2025
268
0.420
Why?
Loperamide
2
2023
11
0.420
Why?
Registries
2
2020
2041
0.420
Why?
Myocardium
3
2017
1002
0.410
Why?
Adult
28
2024
38023
0.400
Why?
Tachycardia, Ventricular
1
2015
175
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2189
0.400
Why?
Diet
1
2021
1279
0.400
Why?
Precision Medicine
6
2024
433
0.400
Why?
Legislation, Medical
1
2012
11
0.390
Why?
Amiodarone
1
2012
26
0.390
Why?
Peripartum Period
4
2022
17
0.380
Why?
Patient Readmission
1
2018
698
0.380
Why?
Phenotype
5
2025
3196
0.380
Why?
Quality Improvement
2
2020
1181
0.370
Why?
Anti-Arrhythmia Agents
1
2012
114
0.370
Why?
Heart Arrest
4
2019
339
0.350
Why?
Catheter Ablation
1
2015
350
0.350
Why?
Sex Factors
4
2024
2077
0.350
Why?
Pyrazines
2
2008
90
0.350
Why?
Treatment Outcome
10
2025
10837
0.350
Why?
Transfusion Reaction
1
2011
45
0.340
Why?
Triazoles
2
2008
147
0.340
Why?
Cardiovascular Diseases
5
2024
2111
0.340
Why?
Forecasting
2
2024
389
0.330
Why?
Postoperative Complications
2
2020
2659
0.330
Why?
Heart-Assist Devices
1
2016
554
0.330
Why?
Echocardiography
3
2024
644
0.330
Why?
Insurance, Health
1
2012
283
0.320
Why?
Patient Transfer
1
2012
176
0.320
Why?
Patient Discharge
2
2021
897
0.320
Why?
Databases, Factual
5
2020
1357
0.310
Why?
Anemia
1
2011
170
0.310
Why?
Thiazolidinediones
1
2010
137
0.310
Why?
Risk Factors
9
2024
10407
0.300
Why?
Aged, 80 and over
7
2024
7637
0.300
Why?
Marketing
1
2008
30
0.300
Why?
Genotype
3
2024
1917
0.300
Why?
Rhabdomyolysis
1
2008
21
0.300
Why?
Renal Insufficiency
1
2011
162
0.300
Why?
Simvastatin
1
2008
61
0.290
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
47
0.290
Why?
Heart Ventricles
4
2017
790
0.280
Why?
Receptors, Adrenergic, beta-1
4
2019
46
0.280
Why?
Heart Rate
3
2025
824
0.280
Why?
Length of Stay
4
2024
1215
0.280
Why?
Electrocardiography
4
2019
629
0.270
Why?
Cytochrome P-450 CYP2D6
3
2022
30
0.270
Why?
Kaplan-Meier Estimate
3
2016
889
0.270
Why?
Drug Industry
1
2008
111
0.270
Why?
Proportional Hazards Models
4
2021
1266
0.270
Why?
Practice Patterns, Physicians'
3
2020
1313
0.260
Why?
Pharmacovigilance
2
2024
23
0.260
Why?
Elective Surgical Procedures
2
2020
179
0.250
Why?
Follow-Up Studies
6
2024
5136
0.250
Why?
Incidence
5
2024
2804
0.250
Why?
Biological Specimen Banks
3
2024
102
0.250
Why?
Emergency Service, Hospital
2
2020
2072
0.240
Why?
Patient Reported Outcome Measures
2
2020
403
0.240
Why?
Gene Expression Regulation
1
2015
2607
0.240
Why?
Cause of Death
2
2019
436
0.230
Why?
Glucose
1
2010
1020
0.220
Why?
New York
1
2024
126
0.220
Why?
Diabetic Cardiomyopathies
1
2024
36
0.220
Why?
Pandemics
3
2022
1639
0.220
Why?
Young Adult
9
2022
13240
0.220
Why?
Pregnancy
6
2022
6771
0.210
Why?
Acute Kidney Injury
2
2008
815
0.210
Why?
Diphenoxylate
1
2023
5
0.210
Why?
Randomized Controlled Trials as Topic
3
2021
1478
0.210
Why?
Adolescent
10
2020
21574
0.200
Why?
Nonprescription Drugs
1
2023
63
0.200
Why?
Monitoring, Physiologic
1
2024
283
0.190
Why?
Heart Defects, Congenital
2
2020
851
0.190
Why?
Medicare
2
2020
773
0.190
Why?
Prognosis
5
2020
4039
0.190
Why?
Naltrexone
1
2023
97
0.190
Why?
Insulin Resistance
1
2010
1211
0.180
Why?
Time Factors
3
2020
6834
0.180
Why?
Speech
1
2021
70
0.180
Why?
Red Meat
1
2021
19
0.170
Why?
Smartphone
1
2021
91
0.170
Why?
Drug Dosage Calculations
1
2020
23
0.170
Why?
Losartan
1
2020
14
0.170
Why?
Lisinopril
1
2020
13
0.170
Why?
Data Interpretation, Statistical
2
2020
363
0.170
Why?
Actigraphy
1
2021
110
0.170
Why?
Protective Factors
1
2021
93
0.170
Why?
Hypoglycemic Agents
1
2010
1294
0.170
Why?
Angioedema
1
2020
16
0.170
Why?
Cardiac Resynchronization Therapy
1
2021
46
0.170
Why?
Hypertension
2
2020
1298
0.170
Why?
Wearable Electronic Devices
1
2021
53
0.170
Why?
American Heart Association
2
2019
306
0.170
Why?
Turner Syndrome
1
2021
54
0.170
Why?
Referral and Consultation
2
2017
786
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Milk
1
2021
124
0.160
Why?
Indans
1
2020
11
0.160
Why?
Biological Products
1
2023
219
0.160
Why?
California
2
2012
431
0.160
Why?
Oxadiazoles
1
2020
33
0.160
Why?
Bionics
1
2019
12
0.160
Why?
Editorial Policies
1
2020
52
0.160
Why?
Medical Futility
1
2019
23
0.160
Why?
Medical Informatics
1
2020
101
0.160
Why?
Software
2
2015
665
0.160
Why?
Fingolimod Hydrochloride
1
2020
40
0.160
Why?
Medical Record Linkage
1
2020
65
0.160
Why?
Prescription Drugs
1
2020
109
0.150
Why?
Information Storage and Retrieval
1
2020
118
0.150
Why?
Drug Overdose
1
2023
347
0.150
Why?
Drug Prescriptions
1
2021
245
0.150
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
76
0.150
Why?
Sitagliptin Phosphate
2
2008
33
0.150
Why?
Medical Order Entry Systems
1
2019
43
0.150
Why?
Child Health Services
1
2020
184
0.150
Why?
Dose-Response Relationship, Drug
4
2020
2057
0.150
Why?
Tobacco Use
1
2019
64
0.140
Why?
Cohort Studies
3
2021
5750
0.140
Why?
Social Determinants of Health
1
2022
268
0.140
Why?
Computer Graphics
2
2015
42
0.140
Why?
Cluster Analysis
1
2019
501
0.140
Why?
Gene Regulatory Networks
2
2023
305
0.140
Why?
Receptors, Histamine H2
1
2017
8
0.140
Why?
Florida
1
2018
107
0.140
Why?
Advisory Committees
1
2019
219
0.140
Why?
Porins
1
1997
13
0.140
Why?
Neisseria gonorrhoeae
1
1997
26
0.130
Why?
Dyslipidemias
1
2019
176
0.130
Why?
Prospective Studies
4
2021
7623
0.130
Why?
Academic Medical Centers
1
2020
512
0.130
Why?
Nursing Assessment
1
2017
59
0.130
Why?
Antihypertensive Agents
1
2020
494
0.130
Why?
Heart Diseases
1
2020
346
0.130
Why?
Pressure Ulcer
1
2017
46
0.130
Why?
Patient Participation
1
2020
426
0.130
Why?
Cardiology
1
2019
274
0.130
Why?
Population Surveillance
1
2020
482
0.130
Why?
Hospitals, Teaching
1
2017
118
0.130
Why?
Tilidine
1
2016
2
0.130
Why?
Consensus
1
2019
683
0.120
Why?
Double-Blind Method
3
2025
1997
0.120
Why?
Genetic Markers
1
2017
344
0.120
Why?
Oxycodone
1
2016
42
0.120
Why?
Databases, Genetic
1
2017
237
0.120
Why?
Rheumatic Heart Disease
1
2015
7
0.120
Why?
Rheumatic Fever
1
2015
10
0.120
Why?
Sex Distribution
1
2016
375
0.120
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.120
Why?
Cholesterol Ester Transfer Proteins
1
2015
20
0.120
Why?
Hospitals, Low-Volume
1
2015
22
0.120
Why?
Angiotensin II
1
2015
99
0.110
Why?
Naloxone
1
2016
122
0.110
Why?
Computational Biology
2
2017
644
0.110
Why?
Gene Expression Profiling
3
2017
1775
0.110
Why?
Hospitals, High-Volume
1
2015
44
0.110
Why?
Immunosuppressive Agents
1
2020
894
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
767
0.110
Why?
Marijuana Use
1
2018
206
0.110
Why?
Percutaneous Coronary Intervention
1
2020
480
0.110
Why?
Mothers
1
2020
759
0.110
Why?
United Kingdom
1
2015
318
0.110
Why?
Biomarkers
2
2024
4154
0.110
Why?
International Classification of Diseases
1
2015
135
0.110
Why?
Age Factors
2
2019
3305
0.110
Why?
Comorbidity
1
2019
1623
0.110
Why?
Chronic Disease
2
2020
1794
0.100
Why?
Narcotic Antagonists
1
2015
181
0.100
Why?
Gene Expression
2
2017
1502
0.100
Why?
Ventricular Dysfunction, Left
2
2020
382
0.100
Why?
Down-Regulation
1
2015
657
0.100
Why?
Cholesterol
1
2015
410
0.100
Why?
MicroRNAs
2
2017
692
0.100
Why?
Coronary Artery Disease
1
2019
698
0.100
Why?
Federal Government
1
2012
28
0.100
Why?
Myocytes, Cardiac
1
2017
526
0.100
Why?
RNA, Messenger
2
2017
2834
0.090
Why?
Drug Resistance
1
2012
169
0.090
Why?
Area Under Curve
1
2012
314
0.090
Why?
Genetic Predisposition to Disease
2
2017
2427
0.090
Why?
Patient Safety
1
2015
315
0.090
Why?
Predictive Value of Tests
1
2017
2041
0.090
Why?
Colorado
4
2024
4576
0.090
Why?
Opiate Substitution Treatment
1
2013
155
0.090
Why?
Gastrointestinal Hemorrhage
1
2012
133
0.090
Why?
Anti-Retroviral Agents
1
2013
233
0.090
Why?
Pregnancy Outcome
1
2013
416
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
1042
0.090
Why?
Survival Rate
1
2015
1973
0.080
Why?
Bayes Theorem
1
2012
407
0.080
Why?
Managed Care Programs
2
2022
135
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
228
0.080
Why?
Genome-Wide Association Study
1
2017
1431
0.080
Why?
Delivery of Health Care
1
2017
951
0.080
Why?
Emergency Medical Services
1
2015
552
0.080
Why?
Multivariate Analysis
1
2012
1509
0.080
Why?
Severity of Illness Index
1
2017
2836
0.070
Why?
Pharmacogenomic Variants
2
2019
35
0.070
Why?
Primary Health Care
1
2019
1750
0.070
Why?
Drug Approval
1
2008
88
0.070
Why?
Vasodilator Agents
1
2010
331
0.070
Why?
Logistic Models
1
2012
2075
0.070
Why?
Kidney Function Tests
1
2007
160
0.070
Why?
Animals
3
2023
36951
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
250
0.060
Why?
Zimbabwe
2
2017
58
0.060
Why?
Opioid-Related Disorders
1
2013
515
0.060
Why?
Drug Therapy, Combination
1
2008
1067
0.060
Why?
Models, Biological
1
2012
1783
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.060
Why?
Case-Control Studies
1
2012
3569
0.060
Why?
Depression
2
2022
1408
0.050
Why?
Psychological Tests
1
2005
140
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
42
0.050
Why?
Potassium Channels
1
2025
151
0.050
Why?
Cross-Sectional Studies
3
2022
5478
0.050
Why?
Mandible
1
2004
78
0.050
Why?
Receptors, Adrenergic
1
2023
33
0.050
Why?
Drug Administration Schedule
2
2020
786
0.050
Why?
Cardiovascular Agents
1
2025
159
0.050
Why?
Algorithms
3
2020
1704
0.050
Why?
Carcinoembryonic Antigen
1
2002
39
0.050
Why?
Antigens, Differentiation
1
2002
83
0.050
Why?
Child
5
2020
21989
0.050
Why?
Antigens, Bacterial
1
2002
127
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
181
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
33
0.040
Why?
Insurance Claim Reporting
1
2020
24
0.040
Why?
Antidepressive Agents
1
2022
236
0.040
Why?
Lymphocyte Count
1
2020
148
0.040
Why?
Morbidity
1
2020
324
0.040
Why?
Antigens, Neoplasm
1
2002
319
0.040
Why?
Membrane Glycoproteins
1
2002
500
0.040
Why?
Antineoplastic Agents
1
2010
2129
0.040
Why?
Grounded Theory
1
2019
36
0.040
Why?
Metoprolol
1
2019
40
0.040
Why?
Antigens, CD
1
2002
521
0.040
Why?
Aftercare
1
2020
208
0.040
Why?
Bias
1
2020
218
0.040
Why?
HIV Infections
1
2013
2837
0.040
Why?
Genomics
1
2024
795
0.040
Why?
Mice, Transgenic
1
2023
2167
0.040
Why?
Coronary Angiography
1
2020
317
0.040
Why?
Delivery of Health Care, Integrated
1
2020
262
0.030
Why?
Amino Acid Sequence
2
2002
2139
0.030
Why?
Static Electricity
1
1997
118
0.030
Why?
Exercise Test
1
2020
632
0.030
Why?
Molecular Sequence Data
2
2002
2900
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
80
0.030
Why?
Inpatients
1
2021
500
0.030
Why?
Focus Groups
1
2019
530
0.030
Why?
Frail Elderly
1
2017
131
0.030
Why?
Socioeconomic Factors
1
2020
1290
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
346
0.030
Why?
Puerperal Disorders
1
2016
31
0.030
Why?
Metabolic Networks and Pathways
1
2017
180
0.030
Why?
Physician-Patient Relations
1
2020
558
0.030
Why?
World Health Organization
1
2016
123
0.030
Why?
Neoplasms
1
2010
2673
0.030
Why?
Drug Combinations
1
2016
343
0.030
Why?
Decision Trees
1
2015
93
0.030
Why?
Data Mining
1
2015
116
0.030
Why?
Cell Membrane
1
1997
738
0.030
Why?
Blood Pressure
1
2020
1789
0.030
Why?
Biopsy
1
2017
1130
0.030
Why?
Reproducibility of Results
1
2020
3290
0.020
Why?
Pediatrics
1
2020
1103
0.020
Why?
Models, Genetic
1
2015
600
0.020
Why?
Infant
2
2015
9482
0.020
Why?
Mass Screening
2
2013
1288
0.020
Why?
Liver
1
2020
1943
0.020
Why?
Anthracyclines
1
2010
42
0.020
Why?
Child, Preschool
2
2015
11105
0.020
Why?
Trastuzumab
1
2010
96
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
92
0.020
Why?
Signal Transduction
1
2023
5081
0.020
Why?
Clinical Trials as Topic
1
2015
1052
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
201
0.020
Why?
Program Evaluation
1
2013
901
0.020
Why?
Apoptosis
1
2017
2553
0.020
Why?
Injections, Intravenous
1
2007
206
0.020
Why?
Natriuretic Peptide, Brain
1
2007
99
0.020
Why?
Infusions, Intravenous
1
2007
413
0.020
Why?
Ultrasonography
1
2010
763
0.020
Why?
Mice
1
2023
17794
0.020
Why?
Creatinine
1
2007
499
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
804
0.010
Why?
Hospitals, University
1
2005
182
0.010
Why?
Dentists
1
2004
20
0.010
Why?
Femur Neck
1
2004
61
0.010
Why?
Bone Diseases, Metabolic
1
2004
63
0.010
Why?
Antibodies, Monoclonal
1
2010
1430
0.010
Why?
Absorptiometry, Photon
1
2004
259
0.010
Why?
Nurses
1
2005
180
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
26
0.010
Why?
Analysis of Variance
1
2004
1316
0.010
Why?
Bone Density
1
2004
489
0.010
Why?
HeLa Cells
1
2002
636
0.010
Why?
Binding Sites
1
2002
1303
0.010
Why?
Clinical Competence
1
2005
1129
0.010
Why?
Physicians
1
2005
914
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)